Piper Sandler Maintains Overweight on Codexis, Lowers Price Target to $8
Piper Sandler analyst Kashy Harrison maintains Codexis (NASDAQ:CDXS) with a Overweight and lowers the price target from $9 to $8.
Stocks · News reference
Dow up 0.20%, NASDAQ down 0.13%, S&P 500 up 0.04%. Real estate shares up 2.3%. Verizon beats earnings, raises guidance. Equities up/down.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Piper Sandler analyst Kashy Harrison maintains Codexis (NASDAQ:CDXS) with a Overweight and lowers the price target from $9 to $8.
Codexis (NASDAQ:CDXS) affirms FY2026 sales outlook from $72.000 million-$76.000 million to $72.000 million-$76.000 million vs $74.099 million estimate.
Codexis (NASDAQ:CDXS) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 7.14 percent. This is a 18.75 percent increase over losses of $(0.16) per share from the same
MaxLinear (MXL) and Vicor (VICR) both benefit from AI infrastructure spending but address different data center bottlenecks. MaxLinear focuses on connectivity through optical and electrical interconnects with already meaningful AI revenues and multiple product ramps planned through 2027-2028. Vicor targets power delivery for AI processors with a stronger balance sheet but earlier-stage technology development. Analysis concludes MXL has the near-term edge despite higher valuation and customer concentration risks.